Abstract
Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by pancytopenia and variable infiltration of the reticuloendothelial system with hairy lymphocytes. HCL is more common in men than women and has a median age of diagnosis of 52 yr. Typically, patients with HCL respond well to purine analog-based therapy. The purpose of this review will be to establish the current status of HCL with respect to its pathophysiology, diagnosis, management, and future directions.
| Original language | English (Ireland) |
|---|---|
| Number of pages | 9 |
| Journal | Medical oncology (Northwood, London, England) |
| Volume | 24 |
| Issue number | 1 |
| Publication status | Published - 1 Jan 2007 |
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Swords R, Giles F
